null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Randomized Phase II Cancer Clinical Trials

List Price: $67.99
SKU:
9780367576455
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Sin-Ho Jung
    Format:
    Paperback
    Pages:
    244
    Publisher:
    CRC Press (June 30, 2020)
    Language:
    English
    ISBN-13:
    9780367576455
    Weight:
    15.875oz
    Dimensions:
    6.125" x 9.1875"
    File:
    TAYLORFRANCIS-TayFran_260515045555544-20260515.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $67.99
    Country of Origin:
    United States
    Series:
    Chapman & Hall/CRC Biostatistics Series
    Case Pack:
    10
    As low as:
    $64.59
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
    Pub Discount:
    30
    Imprint:
    Chapman and Hall/CRC
  • Overview

    Suitable for cancer clinicians and biostatisticians, this book explains how to properly select and accurately use diverse statistical methods for designing and analyzing phase II trials. The author first reviews the statistical methods for single-arm phase II trials since some methodologies for randomized phase II trials stem from single-arm pha